Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-06-09 @ 9:15 PM
Study NCT ID:
NCT01873833
Status:
TERMINATED
Last Update Posted:
2023-10-05
First Post:
2013-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Sponsor:
University of Southern California
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1B-12-10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |